Groff NA Hemplex

Groff North America is a federally licensed biotechnology and pharmaceutical company focused on the cultivation, extraction, and purification of cannabis for medical research. Operating out of a high-security facility known as the Hemplex, the company is one of the few entities authorized by the DEA to produce cannabis-derived materials for federally approved clinical trials. Their services include providing standardized, pharmaceutical-grade cannabis and cannabinoids to researchers and drug developers. By bridging the gap between agricultural production and pharmaceutical standards, Groff NA supports the development of FDA-approved cannabinoid-based therapies.